ALEXANDRIA, Va., Nov. 25 -- United States Patent no. 12,480,096, issued on Nov. 25, was assigned to Universite de Strasbourg (Paris), Institut National de la Sante et de la Recherche Medicale (Strasbourg, France), Institut Hospitalier Universitaire de Strasboug (Strasbourg, France) and ICAHN School of Medicine at Mount Sinai (New York).

"Clinical gene signature-based human cell culture model and uses thereof" was invented by Thomas Baumert (Freiburg, Germany) and Yujin Hoshida (Englewood Cliffs, N.J.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides a simple and robust human liver cell-based system in which persistent hepatitis C infection, persistent hepatitis B infection or etha...